Timing of breast cancer surgery in relation to the menstrual cycle: An update of developments

Critical Reviews in Oncology/Hematology

Volumn 38, Issue 3, 2001, Pages 223-230

  Zurrida, Stefano ^a   Galimberti, Viviana ^a   Gibelli, Bianca ^a   Luini, Alberto ^a   Gianoglio, Simona ^a   Sandri, Maria Teresa ^a   Passerini, Rita ^a   Maisonneuve, Patrick ^a   Zucali, Paolo ^a   Jeronesi, Giulia ^a   Pigatto, Francesca ^a   Veronesi, Umberto ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

Breast cancer; Menstrual cycle; Prognosis; Surgery

Indexed keywords

KI 67 ANTIGEN;

BREAST CANCER; CANCER SURGERY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLICULAR PHASE; HORMONE ACTION; HUMAN; LUTEAL PHASE; MAJOR CLINICAL STUDY; MEDICAL LITERATURE; MENSTRUAL CYCLE; OVULATION; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; REVIEW; TIME;

BREAST NEOPLASMS; FEMALE; HORMONES; HUMANS; MENSTRUAL CYCLE; PROGNOSIS; SURVIVAL RATE; TIME FACTORS;

EID: 17044460010     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1040-8428(00)00128-1     Document Type: Review

References (30)

1. Veronesi U., Salvadori B., Luini A., et al. Breast conservation is a safe method in patients with small cancer of the breast. Long-term results of three randomized trials on 1973 patients. Eur. J. Cancer. 13:(10):1995;1574-1579.
2. Ciatto S., Rosselli del Turco M., Bonardi R., et al. Non-palpable lesions of the breast detected by mammography-Review of 1182 consecutive histologically confirmed cases. Eur. J. Cancer. 30:(1):1994;40-44.
3. Tabar L., Fagerberg G., Duffy S.W., Day N.E., Gad A., Grontoft O., et al. Update of the Swedish two-county program of mammographic screening for breast cancer. Radiol. Clin. North Am. 30:1992;187-210.
4. Veronesi U., Paganelli G., Viale G., et al. Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. J. Natl. Cancer Inst. 91:1999;368-373.
5. Giuliano A.E. Sentinel lymphadenectomy in primary breast carcinoma: an alternative to routine axillary dissection. J. Surg. Oncol. 62:1996;75-77.
6. Early breast cancer trialists' collaborative group: polychemotherapy for early breast cancer: an overview of the randomized trials. Lancet 1998; 352: 930-942.
7. Veronesi U., Luini A., Del Vecchio M., et al. Radiotherapy after breast-preserving surgery in women with localized cancer of the breast. New Engl. Med. 82:1992;1587-1591.
8. Chu K.C., Tarone R.E., Kessler L.G., et al. Recent trends in U.S. breast cancer incidence, survival and mortality rates. J. Natl. Cancer Inst. 88:1996;1571-1579.
9. Vignon F., DeRocq D., Chambon M., et al. Les proteines oestrogen-induites secretes par les cellules mammaires cancereuses humaires MCF-7 stimulent leur proliferation. CR Acad. Sci. 296:1983;151-156.
10. Lippman M.E., Dickson R.B., Bates S., et al. Autocrine and paracrine growth regulation of human breast cancer. Breast Cancer Res. Treat. 7:1986;59-70.
11. Moseson M., Koenig K.L., Shore R.E., Pasternack B.S. The influence of medical conditions associated with hormones on the risk of breast cancer. Int. J. Epidem. 22:(6):1993;1000-1009.
12. Murphy L.J., Ghahary A. Uterin Insulin-like growth factor-1: Regulation of expression and its role in estrogen-induced uterine proliferation. Endocr. Rev. 11:(3):1990;443-453.
13. Ferguson J.E., Schor A.M., Howell A., Ferguson M.V. Changes in the extracellular matrix of the normal human breast during the menstrual cycle. Cell Tissue Res. 268:(1):1992;167-177.
14. Haham H.A., Davidson N.E. Apoptosis in the mammary gland and breast cancer. Endocr. Rel. Cancer. 5:1998;199-211.
15. Lipponen P. Apoptosis in breast cancer: relationship with other pathological parameters. Endocrine Rel. Cancer. 6:1999;13-16.
16. Green S., Furr B. Prospects for the treatment of endocrine-responsive tumors. Endocr. Rel. Cancer. 6:1999;349-371.
17. Goldhirsch A., Gelber R.D., Castiglione M., et al. Menstrual cycle and timing of breast surgery in premenopausal node-positive breast cancer: results of the International Breast Cancer Study Group (IBCSG) Trial VI. Ann. Oncol. 8:1997;751-756.
18. Hagen A.A., Hrushesky J.M. Menstrual timing of breast cancer surgery. Am. J. Surg. 104:1998;245-261.
19. Veronesi U., Luini A., Mariani L., et al. Effect of menstrual phase on surgical treatment of breast cancer. Lancet. 343:1994;1544-1546.
20. Minckwitz G., Kaufmann M., Dobberstein S., Grischke E.M., Diel I.J. Surgical procedure can explain varying influence of menstrual cycle on prognosis of premenopausal breast cancer. The Breast. 4:1995;29-32.
21. Badwe R.A., Wang D.Y., Gregory W.M., et al. Serum progesterone at the time of surgery and survival in women with premenopausal operable breast cancer. Eur. J. Cancer. 30A:(4):1994;445-448.
22. Perren T.J. The timing of breast cancer surgery with respect to the menstrual cycle. More data which emphasize the need for a prospective study. The Breast. 4:1995;1-3.
23. WHO. Histological typing of breast tumours, Second Ed, international histological classification of tumours no 2. Geneva: WHO 1981.
24. Freedman L.S. Tables of the number of patients required in clinical trials using the logrank test. Stat. Med. 1:1982;121-129.
25. McGuire W.L., Hilsenbeck S., Clark G.M. Optimal mastectomy timing. J. Natl. Cancer Inst. 84:1992;346-348.
26. Gruber SA, Nichol KL, Sothern RB, et al. Menstrual history and breast cancer surgery, Breast Cancer Res Treat 1989; 13: 278.
27. Anderson E., Clarke R.B., Howell A. Changes in the normal human breast throughout the menstrual cycle: relevance to breast carcinogenesis. Endocr. Related Cancer. 4:1997;23-33. (Letter).
28. Olsson H., Jernström H., Alm P., et al. Proliferation of the breast epithelium in relation to menstrual cycle phase, hormonal use and reproductive factors. Breast Cancer Res. Treat. 40:1996;187-196.
29. Berrino F., Muti P., Micheli A., et al. Serum sex hormone levels after menopause and subsequent breast cancer. J. Natl. Cancer Inst. 88:1996;291-296.
30. Berardo MD, O'Connell P, Allred DC. Biological characteristics of premalignant and preinvasive breast disease. In: Pasqualini, Katzenellenbogen (Eds.), Hormone dependent Cancer, Dekker, New York 1996. pp. 3-12.